1 – 2 of 2
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
(
- Contribution to journal › Article
- 2006
-
Mark
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
(
- Contribution to journal › Article